All Articles

As Europe embraces small modular reactors and radiopharmaceuticals, Mirion Technologies shifts its flagship safety summit to capture a booming market.

SCIEX introduces compliance software, an open API, and high-resolution oligo kits to the BioPhase 8800, accelerating mRNA therapeutic development.

Fairfax Financial is renewing its massive share repurchase program. Behind the regulatory filing lies a masterclass in capital allocation, liquidity management, and balance sheet optimization.

Engagedly’s 10th annual Top 100 HR Influencers list highlights the shift from administrative oversight to an era defined by AI and autonomous talent strategy.

Dongguk University researchers have developed a flexible, battery-free neuromorphic sensor that converts physical touch into synaptic computing power.

Bouygues Telecom is charging users to block spam calls. As network-level AI replaces apps, the move sparks a fierce debate on who pays for digital safety.

ViaPath's new Threat Alert system promises to solve the deadly blind spots of modern prisons. But can a panic button fix a systemic staffing crisis?

S-Bank has cleared the 90% threshold to acquire Oma Savings Bank, creating a new banking powerhouse and signaling the end of an era for regional retail banking.

Berkshire's Forest River and fintech Aven are turning home equity into instant RV loans. Will this point-of-sale HELOC save dealers or trap consumers?

StreamGo's new CEO Steve Watzeck is betting that the future of water treatment lies not in filtering forever chemicals, but in destroying them entirely.

Ontario’s decision to fund a targeted adult pneumococcal vaccine offers a vital shield for seniors while easing the severe strain on our hospital systems.

By pairing frontier AI with the Model Context Protocol, dv01 is solving the hallucination problem in multi-billion dollar debt deals and reshaping workflows.

As AI rack densities soar, liquid cooling has become a mission-critical utility. A new 20 GW milestone reveals the unseen operational realities of the AI boom.

Trulieve’s perpetual licensing deal with Connected goes beyond corporate strategy—it's a blueprint for expanding equitable patient access to premium medical cannabis.

Bimergen Energy aims to erase a 50% equity overhang to woo institutional partners, but a pending $100M shelf filing reveals a deeper strategic paradox.

A new study reveals it takes nearly 10 workdays to read the privacy terms of a single digital day. Has the "notice and consent" model completely collapsed?

A new partnership highlights how enzymatic synthesis could solve the scaling and stereochemistry crises facing next-generation RNA therapeutics.

MEXC's new CLI tool bridges the gap between AI advisory and market execution, but mixing natural language with high-stakes trading brings new systemic risks.

Perpetua Resources transitions from regulatory battles to heavy earthworks in Idaho, backed by billions in federal funding to secure U.S. critical minerals.

A Chinese hospital claims to functionally cure Type 1 diabetes. But are they selling a medical breakthrough or monetizing a physiological illusion?